Exogenix Information

Next-Generation Exosome Therapeutics | FDA-Aligned | Clinical-Grade | Global Distribution Description: Exogenix is redefining standards in regenerative medicine by providing the only exosome-based injectable biologic manufactured under a 351(a) FDA pathway with an active FDA Master File. Unlike topical serums or research-grade exosomes, our biologics are produced with full clinical oversight, GMP standards, and validated potency — delivering 100B+ CD81+ purified exosomes per vial for consistent, scalable patient outcomes. Who We Serve: We support healthcare providers, aesthetic practices, and pain specialists seeking safe, potent, and compliant regenerative therapies. 💡 What Sets Us Apart: ✅ FDA Master File + IND Pathway (351a Drug) ✅ Injectable + Topical options ✅ GMP manufacturing & ISO-5 cleanroom standards ✅ COA-backed, third-party tested, CD81+ purified ✅ Global distribution & provider support Let’s raise the bar for what regenerative medicine should be. 📍Headquartered in Dallas, TX | Serving global clinical markets